NCT05686837
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
Enrolling by Invitation
Not specifiedAges 1–99ObservationalUniversity of North Carolina, Chapel HillInvestigator-initiated
~100 participants
Updated 2025-10-20 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Epidemiologic Investigation
Measured over 3 years
+2 more outcomes measured
Conditions
Where it's being run
7 sites across 6 statesTexas2
Colorado1
Maryland1
Vermont1
Virginia1
Washington1
Study leadership
- Jane E. Gross, MD, PhD · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Diagnosis of CF consistent with the 2017 CFF guidelines.
Male or female participant of any age who has a history of NTM or a first positive NTM culture collected as part of routine clinical care from expectorated sputum, induced sputum, throat/oropharyngeal swab and/or bronchoalveolar lavage.
Exclusion
No diagnosis of CF
What this trial measures
- Epidemiologic Investigation3 years
Identification of a shared healthcare-associated source(s) between patients in a CF Care Center.
- Dust and Water Biofilm Collection3 years
Identification of healthcare dust and water biofilm NTM isolates that are highly related to the isolates recovered from PwCF.
- Home of Residence Watershed Mapping3 years
The primary endpoint is identification of common watersheds among pwCF infected with clustered NTM isolate.